1. Home
  2. NLY vs PODD Comparison

NLY vs PODD Comparison

Compare NLY & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Annaly Capital Management Inc.

NLY

Annaly Capital Management Inc.

N/A

Current Price

$22.06

Market Cap

16.1B

Sector

Real Estate

ML Signal

N/A

Logo Insulet Corporation

PODD

Insulet Corporation

N/A

Current Price

$235.71

Market Cap

17.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NLY
PODD
Founded
1996
2000
Country
United States
United States
Employees
212
N/A
Industry
Real Estate Investment Trusts
Medical/Dental Instruments
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
16.1B
17.0B
IPO Year
N/A
2007

Fundamental Metrics

Financial Performance
Metric
NLY
PODD
Price
$22.06
$235.71
Analyst Decision
Buy
Strong Buy
Analyst Count
11
20
Target Price
$23.73
$357.65
AVG Volume (30 Days)
6.4M
964.7K
Earning Date
01-01-0001
05-20-2026
Dividend Yield
12.47%
N/A
EPS Growth
N/A
N/A
EPS
N/A
3.48
Revenue
N/A
$2,708,100,000.00
Revenue This Year
$188.83
$24.33
Revenue Next Year
$2.40
$19.33
P/E Ratio
$7.88
$68.63
Revenue Growth
N/A
30.73
52 Week Low
$16.60
$233.29
52 Week High
$24.52
$354.88

Technical Indicators

Market Signals
Indicator
NLY
PODD
Relative Strength Index (RSI) 33.70 36.34
Support Level $20.40 N/A
Resistance Level $22.29 $299.75
Average True Range (ATR) 0.49 6.35
MACD -0.09 0.27
Stochastic Oscillator 25.34 12.73

Price Performance

Historical Comparison
NLY
PODD

About NLY Annaly Capital Management Inc.

Annaly Capital Management Inc is an American mortgage real estate investment trust. Its business objective is to generate net income for distribution to its stockholders and optimize its returns through prudent management of its diversified investment strategies. The company's reportable operating segments are: the Agency segment, which invests in Agency mortgage-backed securities collateralized by residential mortgages; the Residential Credit segment, which invests in non-Agency residential whole loans and securitized products within the residential and commercial markets; the Mortgage Servicing Rights segment; and Corporate & Other. Maximum revenue for the company is generated from its Agency segment.

About PODD Insulet Corporation

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.

Share on Social Networks: